Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2218-2226

  Brodin, Petter ^a,b   Lakshmikanth, Tadepally ^a   Kärre, Klas ^a   Höglund, Petter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; LYMPHOCYTE RECEPTOR; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; H-2 ANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A;

EID: 84857478196     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102801     Document Type: Article

References (48)

1. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502. (Pubitemid 351560518)
2. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848. (Pubitemid 28536771)
3. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678. (Pubitemid 16119452)
4. Ljunggren, H. G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244. (Pubitemid 20198988)
5. Höglund, P., H. G. Ljunggren, C. Öhlén, L. Ährlund-Richter, G. Scangos, C. Bieberich, G. Jay, G. Klein, and K. Kärre. 1988. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J. Exp. Med. 168: 1469-1474. (Pubitemid 18264878)
6. Öhlén, C., G. Kling, P. Höglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay, and K. Kärre. 1989. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246: 666-668. (Pubitemid 19283359)
7. Bix, M., N. S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349: 329-331. (Pubitemid 21912075)
8. Höglund, P., C. Öhlén, E. Carbone, L. Franksson, H. G. Ljunggren, A. Latour, B. Koller, and K. Kärre. 1991. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88: 10332-10336. (Pubitemid 21915829)
9. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202. (Pubitemid 21917142)
10. Öhlén, C., P. Höglund, C. L. Sentman, E. Carbone, H. G. Ljunggren, B. Koller, and K. Kärre. 1995. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur. J. Immunol. 25: 1286-1291.
11. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423. (Pubitemid 40720789)
12. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713. (Pubitemid 41117274)
13. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342. (Pubitemid 44224147)
14. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon- Divon, F. Lemonnier, K. Kärre, and P. Höglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201: 1145-1155. (Pubitemid 40524682)
15. Yawata, M., N. Yawata, M. Draghi, F. Partheniou, A. M. Little, and P. Parham. 2008. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112: 2369-2380.
16. Brodin, P., T. Lakshmikanth, S. Johansson, K. Kärre, and P. Höglund. 2009. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113: 2434-2441.
17. Brodin, P., K. Kärre, and P. Höglund. 2009. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 30: 143-149.
18. Joncker, N. T., N. C. Fernandez, E. Treiner, E. Vivier, and D. H. Raulet. 2009. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 182: 4572-4580.
19. Held, W., D. Cado, and D. H. Raulet. 1996. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 184: 2037-2041. (Pubitemid 26404495)
20. Salcedo, M., A. D. Diehl, M. Y. Olsson-Alheim, J. Sundbäck, L. VanKaer, K. Kärre, and H. G. Ljunggren. 1997. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J. Immunol. 158: 3174-3180. (Pubitemid 127484031)
21. Johansson, S., M. Salmon-Divon, M. H. Johansson, Y. Pickman, P. Brodin, K. Kärre, R. Mehr, and P. Höglund. 2009. Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE 4: e6046.
22. Guia, S., B. N. Jaeger, S. Piatek, S. Mailfert, T. Trombik, A. Fenis, N. Chevrier, T.Walzer, Y.M. Kerdiles, D. Marguet, et al. 2011. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci. Signal. 4: ra21.
23. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
24. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631. (Pubitemid 129516325)
25. Natarajan, K., L. F. Boyd, P. Schuck, W. M. Yokoyama, D. Eliat, and D. H. Margulies. 1999. Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity 11: 591-601.
26. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258. (Pubitemid 351432801)
27. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
28. Fahlén, L., U. Lendahl, and C. L. Sentman. 2001. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J. Immunol. 166: 6585-6592. (Pubitemid 32467198)
29. Huntington, N. D., C. A. Vosshenrich, and J. P. Di Santo. 2007. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7: 703-714. (Pubitemid 47327395)
30. Das, J. 2010. Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner. Biophys. J. 99: 2028-2037.
31. Held, W., J. R. Dorfman, M. F. Wu, and D. H. Raulet. 1996. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26: 2286-2292. (Pubitemid 26340925)
32. Doucey, M. A., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336. (Pubitemid 38332130)
33. Chalifour, A., L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy, G. Leclercq, P. Höglund, F. Beermann, and W. Held. 2009. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30: 337-347.
34. Held, W., and D. H. Raulet. 1997. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 185: 2079-2088. (Pubitemid 27265991)
35. George, T. C., J. R. Ortaldo, S. Lemieux, V. Kumar, and M. Bennett. 1999. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J. Immunol. 163: 1859-1867. (Pubitemid 29382186)
36. Horng, T., J. S. Bezbradica, and R. Medzhitov. 2007. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8: 1345-1352. (Pubitemid 350138973)
37. Bezbradica, J. S., and R. Medzhitov. 2009. Integration of cytokine and heterologous receptor signaling pathways. Nat. Immunol. 10: 333-339.
38. Jonsson, A. H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
39. Fauriat, C., S. Andersson, A. T. Björklund, M. Carlsten, M. Schaffer, N. K. Björkström, B. C. Baumann, J. Michaëlsson, H. G. Ljunggren, and K. J. Malmberg. 2008. Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J. Immunol. 181: 6010-6019.
40. Fauriat, C., M. A. Ivarsson, H. G. Ljunggren, K. J. Malmberg, and J. Michaëlsson. 2010. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115: 1166-1174.
41. Kim, S., J. B. Sunwoo, L. Yang, T. Choi, Y. J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105: 3053-3058. (Pubitemid 351723666)
42. Höglund, P., and P. Brodin. 2010. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 10: 724-734.
43. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947. (Pubitemid 47301321)
44. Thomas, R., R. Apps, Y. Qi, X. Gao, V. Male, C. O'hUigin, G. O'Connor, D. Ge, J. Fellay, J. N. Martin, et al. 2009. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41: 1290-1294.
45. Khakoo, S. I., and M. Carrington. 2006. KIR and disease: a model system or system of models? Immunol. Rev. 214: 186-201. (Pubitemid 44707911)
46. Schönberg, K., M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg. 2011. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117: 98-107.
47. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214. (Pubitemid 40364822)
48. Peterson, M. E., and E. O. Long. 2008. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29: 578-588.